A low anti-Müllerian hormone (AMH) level usually reflects a smaller-than-average pool of growing follicles in the ovaries, and the single most common reason is age. But age is far from the only explanation. Ovarian surgery, endometriosis, autoimmune disease, chemotherapy, smoking, certain genetic conditions, and even the hormonal contraceptive you are currently taking can all push AMH down, sometimes temporarily. Understanding which of these applies to you changes what the number actually means for your fertility and your health.
What AMH Actually Measures
AMH is a hormone produced by the cells surrounding small, growing follicles in the ovary. Your blood level correlates strongly with how many of those growing follicles you have at any given time, which is why clinicians use it as a proxy for ovarian reserve.1PubMed Central. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function The follicles that produce AMH are not the tiny dormant (primordial) ones sitting in storage. AMH expression kicks in once a follicle has been activated and starts developing through the early growth stages.2Journal of Endocrinology. A putative role for anti-Müllerian hormone (AMH) in optimising ovarian reserve expenditure This distinction matters because a low AMH reading tells you about the active, growing portion of your follicle pool. It does not directly count how many dormant follicles remain.
Age Is the Biggest Factor
AMH declines steadily from the mid-twenties onward. In a large U.S. dataset of over 17,000 women, median AMH dropped by roughly 0.2 ng/mL per year through age 35, then slowed to about 0.1 ng/mL per year after that.3PubMed. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States A recent cohort study of nearly 23,000 women found that by age 36, the median AMH had already fallen below 1.2 ng/mL, and by 45, close to 96% of women met criteria for diminished ovarian reserve.4PubMed Central. Age-stratified anti-Müllerian hormone (AMH) nomogram: a comprehensive cohort study including 22,920 women
The trajectory is not identical for everyone. A population-based longitudinal study found that the rate of decline accelerated after 40 but that individual women followed their own patterns rather than one universal curve.5PubMed Central. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline Two women the same age can have very different AMH levels simply because one’s ovarian reserve is naturally larger or depleting more slowly. If your AMH is low for your age, though, something beyond normal aging is worth considering.
Ovarian Surgery
Any operation that removes ovarian tissue removes follicles along with it, and AMH levels drop accordingly. This is well documented for cystectomy, the surgical removal of ovarian cysts. In one prospective study, AMH fell by about a third within three months of surgery, regardless of whether the cyst was an endometrioma or another benign type.6PubMed. Decline of serum antimüllerian hormone levels after laparoscopic ovarian cystectomy in endometrioma and other benign cysts: a prospective cohort study Having cysts on both ovaries made the drop worse. The degree of immediate decline also depends on the cyst type: endometriotic cysts caused roughly a 54% drop in the first week after surgery, while cystic teratomas recovered to about 83% of baseline by three months.7PubMed Central. Effect of Laparoscopic Ovarian Cystectomy on Ovarian Reserve in Benign Ovarian Cysts
Larger cysts (5 cm or more) are associated with a greater post-surgical AMH reduction, while smaller cysts may not shift the number significantly.8PubMed Central. Primary Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation If you have had any ovarian surgery in your history, that alone could explain a lower-than-expected AMH, especially if the procedure involved both ovaries.
Endometriosis
Endometriosis can lower AMH even without surgery. A systematic review and meta-analysis found that women with unoperated ovarian endometriomas had meaningfully lower AMH than women with healthy ovaries or other types of benign cysts.9PubMed. Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis In a study comparing infertile women with endometriosis to those with male-factor infertility, the endometriosis groups had lower average AMH (around 2.5 ng/mL vs. 3.6 ng/mL) and roughly double the odds of having AMH below 1 ng/mL, whether or not they had undergone prior ovarian surgery.10PubMed Central. The effect of endometriosis on the antimüllerian hormone level in the infertile population
The mechanism seems to involve direct damage to the surrounding ovarian tissue by the endometriotic lesions themselves, independent of any surgical intervention. If you have been diagnosed with endometriosis, especially ovarian endometriomas, the condition may be contributing to your low AMH on its own.
Autoimmune Conditions
The ovaries are vulnerable to autoimmune attack. Several chronic inflammatory and autoimmune diseases have been linked to reduced ovarian reserve and lower AMH. A meta-analysis of women with systemic lupus erythematosus (SLE) found their AMH levels were significantly lower than those of healthy controls, and the effect appeared particularly severe in women who developed SLE in adulthood.11PubMed. Effect of systemic lupus erythematosus on the ovarian reserve: A systematic review and meta-analysis
It is not just lupus. A study comparing women with rheumatoid arthritis, a spinal inflammatory condition called spondyloarthritis, and Behçet’s disease to age-matched healthy women found reduced AMH across the board.12Rheumatology. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet’s disease and spondyloarthritis on anti-Müllerian hormone levels Hashimoto’s thyroiditis and type 1 diabetes have also been flagged as potentially harmful to ovarian reserve.13PubMed Central. A review of autoimmunity and immune profiles in patients with primary ovarian insufficiency If you carry any autoimmune diagnosis and your AMH is low, the two may be connected, and it is worth mentioning to your reproductive endocrinologist.
Chemotherapy and Other Gonadotoxic Treatments
Chemotherapy drugs damage the follicles directly, and AMH often drops sharply during treatment. A systematic review confirmed that cancer patients have significantly lower AMH after chemotherapy compared to age-matched controls, reflecting real follicle loss rather than a temporary suppression of the hormone.14PubMed Central. Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review The extent of the damage depends on the specific drug regimen. Alkylating agents are especially harmful, while other regimens are less destructive. In breast cancer patients, AMH decline after chemotherapy pointed to direct damage to the growing follicles.15PubMed Central. Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma For some women AMH partially recovers after treatment ends, but for others the loss is permanent. If you have undergone any cancer treatment, that history is likely relevant to your current levels.
Genetic Factors
Some women are genetically predisposed to a smaller or faster-declining follicle pool. A systematic review identified multiple genes associated with diminished ovarian reserve, including mutations in FMR1, polymorphisms in genes involved in follicle growth signaling, and differences in how AMH and related hormones are expressed.16PubMed Central. Genetic associations with diminished ovarian reserve: a systematic review of the literature The best known of these is the FMR1 premutation, carried by roughly 1 in 200 women, which puts carriers at risk for early ovarian insufficiency.17Human Reproduction. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study Family history can be a clue: if your mother or sisters went through early menopause, a genetic component is plausible.
Smoking
Active smoking appears to directly harm the growing follicle pool. In women aged 38 to 50, current smokers had 44% lower AMH values than women with no smoke exposure, while former smokers showed no significant difference from non-smokers.18PubMed Central. The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years That finding suggests the damage may target the actively growing follicles rather than the dormant reserve, and that quitting may stop further damage. A separate study in women seeking fertility care found a dose-response pattern: for every additional cigarette smoked per day, the odds of diminished ovarian reserve rose by about 8%.19PubMed Central. Association between cigarette smoking and ovarian reserve among women seeking fertility care If you currently smoke, it is one of the few modifiable contributors to low AMH.
Hormonal Contraceptives Can Temporarily Lower Your Reading
This is one of the most underappreciated sources of a misleadingly low AMH. Current users of hormonal contraceptives had roughly 25% lower AMH levels than non-users in a large study, yet former users showed no meaningful difference from women who had never used them, confirming the effect is reversible.20PubMed Central. Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels A population study of over 42,000 women found that the suppressive effect varied by method: the combined oral contraceptive pill lowered AMH by about 17% on average, while the hormonal IUD had essentially no effect.21PubMed. Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women
The suppression was disproportionately larger at lower AMH percentiles. A woman whose true AMH is already on the low end could see her reading drop by roughly a third while on the pill, potentially pushing her into a “diminished reserve” classification that does not actually reflect her underlying follicle count.21PubMed. Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women If you had your AMH tested while on hormonal contraception, the result may be significantly lower than your true baseline. Some clinicians recommend waiting at least a few months after discontinuing before drawing blood for AMH, and one analysis found that women under 30 who waited two to three years after stopping long-term hormonal contraception had notably higher measured AMH than those tested within two years of stopping.22PubMed Central. The Effect of Hormonal Contraception Use on Ovarian Reserve Markers and the Uptake of Assisted Reproductive Technology in Individuals Seeking an Infertility Evaluation
Race, Ethnicity, and Vitamin D
AMH reference ranges are not identical across racial and ethnic groups. Multiple studies have found that Black and Hispanic women tend to have lower AMH than age-matched white women, while Chinese women show higher AMH before age 25.23PubMed Central. Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A Review The reasons are not fully understood but may involve differences in the rate of follicle activation, body composition, and genetic factors.24PubMed Central. Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve This matters practically because most AMH reference ranges were established in predominantly white populations. A “low” result by those standards may be perfectly normal for you.
Vitamin D status is another variable that gets overlooked. The AMH gene promoter contains a vitamin D response element, and at least one study found that vitamin D levels correlated positively with AMH in women, raising the possibility that vitamin D deficiency could make AMH readings look worse than the underlying follicle count warrants.25The Journal of Clinical Endocrinology & Metabolism. The Level of Serum Anti-Müllerian Hormone Correlates with Vitamin D Status in Men and Women But Not in Boys Whether correcting a vitamin D deficiency meaningfully raises AMH is still being studied, but it is another reason a single low number should not be read in isolation.
Test-to-Test Variability
AMH is more stable across the menstrual cycle than older hormones like FSH, but that does not mean it never fluctuates. One study found a median cycle-to-cycle variation of over 44%, which was large enough that about 20% of patients were reclassified between “normal responder” and “poor responder” categories on a second test.26PubMed Central. Inter-cycle variability of anti-Müllerian hormone: implications for predicting controlled ovarian stimulation cycle outcomes Factors like BMI, ethnicity, and smoking contribute to inter-individual variability as well.27PubMed Central. How Much Does AMH Really Vary in Normal Women? If you got one low reading and are panicking, repeating the test in a subsequent cycle is reasonable before drawing firm conclusions.
What Low AMH Means for Getting Pregnant
Here is where the science departs from the anxiety a low result creates. AMH tells you about ovarian reserve, which correlates strongly with how many eggs you are likely to produce during an IVF cycle. It does not tell you much about egg quality, and it is a surprisingly poor predictor of natural conception. A 2024 study of infertile women found no significant difference in the proportion of women with AMH below 0.7 ng/mL between those with unexplained infertility and those whose infertility was entirely due to a male partner. Low ovarian reserve markers did not predict worse odds of conceiving on their own.28PubMed Central. Ovarian reserve does not influence natural conception: insights from infertile women
For IVF specifically, low AMH does predict fewer eggs retrieved and higher cycle cancellation rates. In one study of women with very low AMH, about 15% of cycles were cancelled before egg retrieval. But among those who did reach retrieval, age mattered far more than AMH for pregnancy rates: women under 35 had a clinical pregnancy rate of 31% per retrieval, compared to about 10% in women 40 to 43, despite comparable AMH levels.29PubMed Central. IVF results in patients with very low serum AMH are significantly affected by chronological age Even in extremely low AMH ranges, ongoing pregnancy rates per patient reached about 16 to 20%.30PLoS ONE. Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 Cycles The bottom line is that low AMH makes IVF harder and less efficient, but it does not make pregnancy impossible, and your age at the time of the cycle has a larger impact on whether a retrieved egg becomes a baby.
AMH and Menopause Timing
Because AMH tracks the remaining pool of growing follicles, it can offer a rough forecast of when menopause will arrive. In one longitudinal study, women aged 35 to 39 with AMH below 0.20 ng/mL had a median time to menopause of about 10 years, while those in the 45 to 48 age group with the same low AMH reached menopause in roughly 6 years. Higher AMH levels pushed the estimated menopause further out at every age.31PubMed Central. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women Another study confirmed that combining AMH with age produced strong predictive accuracy for when menopause would occur.32The Journal of Clinical Endocrinology & Metabolism. Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women
That said, these are population-level statistics. On an individual basis, the prediction windows remain wide. A review of the evidence concluded that while AMH is clearly related to menopause timing, it is “insufficiently precise to inform on an individual’s journey of ovarian aging.”33PubMed Central. Role of AMH in Prediction of Menopause A low AMH at 32 does not mean menopause at 38. It means your timeline is probably shorter than average, but no one can pin the date down with useful accuracy.
Can Supplements or Treatments Raise AMH?
No intervention has been proven to restore a depleted follicle pool. You cannot grow new eggs. However, a few supplements have shown modest effects on AMH levels and IVF outcomes in women with diminished ovarian reserve. A meta-analysis of oral supplements found that combinations of vitamins, coenzyme Q10 (CoQ10), and DHEA led to small but statistically significant increases in AMH, follicle counts, and the number of eggs retrieved during IVF, along with higher clinical pregnancy rates. The benefits were more pronounced when supplementation lasted longer than two months.34PubMed Central. The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: a systematic review and meta-analysis
Among individual supplements, CoQ10 showed particular promise. A network meta-analysis comparing several interventions for poor ovarian responders undergoing IVF found CoQ10 had the best odds of improving live birth rates, while DHEA was strongest for embryo implantation and the number of eggs retrieved.35PubMed Central. TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis These are not miracle cures. The improvements are modest, and the evidence is still evolving. But for women about to enter an IVF cycle with low reserve, a conversation with your doctor about CoQ10 or DHEA supplementation is reasonable.
The Emotional Weight of a Low Result
Clinicians sometimes underestimate how much a low AMH result upends a patient’s emotional world. Qualitative research has found that receiving a low AMH result carries significant psychological impact, including anxiety, grief, and a feeling that time is running out.36PubMed. “So what happens next?” exploring the psychological and emotional impact of anti-Mullerian hormone testing In a large survey, nearly half of women who had AMH testing perceived their result as “low,” and that perception was linked to greater emotional distress, increased decisional regret about having been tested, and changes in reproductive plans like rushing into egg freezing or fertility treatment.37Human Reproduction. The psychosocial and behavioural consequences of anti-müllerian hormone (AMH) testing on women
Some of those decisions may be entirely appropriate. Others may be reactions to a number that, as outlined above, can be temporarily suppressed by contraceptives, affected by vitamin D deficiency, inflated by test-to-test variability, or simply reflect a normal range for your ethnicity and age. If you are sitting with a low AMH result and feeling a sense of urgency, it is worth stepping back and confirming that the number was measured under ideal conditions, understanding exactly what it does and does not predict, and working with a specialist who can put the result into the full clinical picture before you change your life plans around a single blood draw.